Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2014 | 12-2013 | 09-2013 | 06-2013 | 03-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -760 | -3,710 | -1,900 | -2,340 | -1,100 |
| Depreciation Amortization | 0 | N/A | 230 | 150 | 70 |
| Accounts receivable | N/A | -50 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | -86 | N/A | N/A | N/A |
| Other Working Capital | 0 | 1,210 | -570 | -270 | -120 |
| Other Operating Activity | -30 | 146 | 270 | 1,240 | 600 |
| Operating Cash Flow | $-790 | $-2,490 | $-1,970 | $-1,220 | $-550 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6 | -80 | -10 | -10 | -8 |
| Net Acquisitions | 0 | 0 | 2,720 | 0 | 0 |
| Sale Of Investment | N/A | 3,054 | N/A | N/A | N/A |
| Other Investing Activity | 276 | 356 | 1,570 | 500 | 508 |
| Investing Cash Flow | $270 | $3,330 | $4,280 | $490 | $500 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 317 | N/A | N/A | N/A |
| Other Financing Activity | 230 | -7 | 140 | 10 | 9 |
| Financing Cash Flow | $230 | $310 | $140 | $10 | $9 |
| Exchange Rate Effect | -4 | 30 | 1 | 3 | 10 |
| Beginning Cash Position | 2,880 | 1,690 | 1,690 | 1,690 | 1,690 |
| End Cash Position | 2,590 | 2,880 | 4,140 | 990 | 1,660 |
| Net Cash Flow | $-290 | $1,190 | $2,440 | $-700 | $-20 |
| Free Cash Flow | |||||
| Operating Cash Flow | -790 | -2,490 | -1,970 | -1,220 | -550 |
| Capital Expenditure | N/A | -84 | N/A | N/A | N/A |
| Free Cash Flow | -790 | -2,574 | -1,970 | -1,220 | -550 |